In this issue:
- Consensus on corticosteroid management in IBD RCTs
- Obefazimod in moderate-to-severely active UC
- Temporal trends in surgical treatment of IBD with biological drugs
- 24-Nor-ursodeoxycholic acid effects on intestinal inflammation
- Antibiotic use and risk of microscopic colitis
- Obesity and novel management of IBD
- GLP-1 receptor agonists in IBD
- GLP-1 receptor agonists for type 2 diabetes mellitus and IBD outcomes
- GLP-1 receptor agonists in IBD and other inflammatory conditions
- Science blog: GlycoCaging in IBD
Please login below to download this issue (PDF)